We did a randomised , double-blind , placebo-controlled three-group phase @ trial of daily oral tenofovir disoproxil fumarate and emtricitabine plus tenofovir disoproxil fumarate PrEP in HIV-@ uninfected individuals in heterosexual HIV-@ serodiscordant couples from Kenya and Uganda .